Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Quarterly results
Inv. presentation
Director departure

Adverum Biotechnologies, Inc. (ADVM) Create: Alert

All | News | Filings
Date FiledTypeDescription
06/09/2023 4 Rubinstein Linda M (CFO) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Bought 100,000 shares @ $1.4549, valued at $145.5k
03/17/2023 4 Riley Brigit (Chief Scientific Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Sold 7,299 shares @ $0.7816, valued at $5.7k
03/17/2023 4 Soparkar Peter (COO) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Sold 13,360 shares @ $0.7816, valued at $10.4k
03/17/2023 4 Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Sold 41,239 shares @ $0.7816, valued at $32.2k
12/15/2022 3 Rubinstein Linda M (CFO) has filed a Form 3 on Adverum Biotechnologies, Inc.
09/21/2022 4 Beckman Richard (Chief Medical Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Sold 4,272 shares @ $1.0697, valued at $4.6k
09/21/2022 4 Seyedkazemi Setareh (Chief Development Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Sold 6,058 shares @ $1.0696, valued at $6.5k
09/21/2022 4 Soparkar Peter (See Remarks section) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Sold 13,305 shares @ $1.0697, valued at $14.2k
09/21/2022 4 Riley Brigit (Chief Scientific Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Sold 7,266 shares @ $1.0697, valued at $7.8k
09/21/2022 4 Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Sold 41,082 shares @ $1.0696, valued at $43.9k
09/21/2022 4/A Beckman Richard (Chief Medical Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Granted 33,333 shares @ $0
09/16/2022 4 Beckman Richard (Chief Medical Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Granted 25,000 shares @ $0
09/16/2022 4 Seyedkazemi Setareh (Chief Development Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Granted 33,333 shares @ $0
09/16/2022 4 Riley Brigit (Chief Scientific Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Granted 95,931 options to buy @ $1.09, valued at $104.6k
Granted 68,482 options to buy @ $1.09, valued at $74.6k
09/16/2022 4 Rakow John (SVP, Genl Counsel, Acting CFO) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Granted 42,813 options to buy @ $1.09, valued at $46.7k
Granted 75,257 options to buy @ $1.09, valued at $82k
09/16/2022 4 Soparkar Peter (See Remarks section) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Granted 163,847 options to buy @ $1.09, valued at $178.6k
Granted 230,924 options to buy @ $1.09, valued at $251.7k
09/16/2022 4 Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Granted 675,022 options to buy @ $1.09, valued at $735.8k
Granted 584,978 options to buy @ $1.09, valued at $637.6k
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/14/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
06/07/2022 3 Form 3 - Initial statement of beneficial ownership of securities:
05/24/2022 4 Seyedkazemi Setareh (Chief Development Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Bought 20,000 shares @ $0.84, valued at $16.8k
05/19/2022 4 Beckman Richard (Chief Medical Officer) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Bought 10,000 shares @ $0.8228, valued at $8.2k
05/18/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/17/2022 4 D'Souza Rupert (CFO) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Bought 10,000 shares @ $0.8585, valued at $8.6k
Bought 10,000 shares @ $0.8272, valued at $8.3k
04/22/2022 4 Fischer Laurent (CEO, President and Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Bought 25,000 shares @ $1.112, valued at $27.8k
04/20/2022 4 Soparkar Peter (See Remarks section) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Bought 175 shares @ $1.1373, valued at $199
Bought 21,750 shares @ $1.14, valued at $24.8k
03/18/2022 4 Hong Soo (Director) has filed a Form 4 on Adverum Biotechnologies, Inc.
Txns: Granted 80,000 options to buy @ $1.35, valued at $108k
03/18/2022 3 Hong Soo (Director) has filed a Form 3 on Adverum Biotechnologies, Inc.
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy